LOCAL ADVANCED ESOPHAGEAL CANCER

Clinical trials for LOCAL ADVANCED ESOPHAGEAL CANCER explained in plain language.

Never miss a new study

Get alerted when new LOCAL ADVANCED ESOPHAGEAL CANCER trials appear

Sign up with your email to follow new studies for LOCAL ADVANCED ESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for esophageal cancer patients after standard treatment fails

Disease control Not yet recruiting

This study tests whether a combination of two immunotherapy drugs (Iparomlimab and Tuvonralimab) plus chemoradiotherapy can help people with locally advanced esophageal cancer whose prior chemo-immunotherapy did not work. About 40 adults aged 18-75 will receive the treatment, and…

Matched conditions: LOCAL ADVANCED ESOPHAGEAL CANCER

Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

LOCAL ADVANCED ESOPHAGEAL CANCER

Get alerted when new LOCAL ADVANCED ESOPHAGEAL CANCER trials appear

New hope for esophageal cancer patients after standard treatment fails